Patent · US Active

Monoclonal antibodies to human CTLA-8 (IL-17A)

US7879980B2 · kind B2 · utility

5Cited by

6References

16Claims

0Family size

Assignees

SCHERING CORPORATION · US
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Pierre Golstein · Marseilles, FR
Eric Rouvier · Marseille, FR
Francois Fossiez · Craponne, FR
Serge Lebecque · Écully, FR
Odile Djossou · Lyon, FR
Jacques F. Banchereau · Montclair, US

Key dates

Filing date	Oct 31, 2007
Grant date	Feb 1, 2011
Priority date	—
Expiry date	Aug 5, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/975
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Human CTLA-8 protein, antibodies that specifically bind to human CTLA-8, and nucleic acids encoding human CTLA-8. Methods of using these molecules and diagnostic kits are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.